Investment Research & Advisory Group’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-110
Closed -$8.19K 317
2026
Q1
$8.19K Hold
110
﹤0.01% 209
2025
Q4
$9.76K Hold
110
﹤0.01% 194
2025
Q3
$9.01K Hold
110
﹤0.01% 180
2025
Q2
$8.15K Buy
110
+77
+233% +$5.36K ﹤0.01% 178
2025
Q1
$2.66K Buy
+33
New +$2.84K ﹤0.01% 214
2024
Q2
Sell
-708
Closed -$64.4K 210
2024
Q1
$64.4K Buy
708
+359
+103% +$29.9K 0.03% 91
2023
Q4
$27K Hold
349
0.01% 114
2023
Q3
$23.7K Sell
349
-4,312
-93% -$314K 0.01% 118
2023
Q2
$379K Buy
4,661
+479
+11% +$38.2K 0.22% 56
2023
Q1
$343K Buy
+4,182
New +$299K 0.22% 55

Other funds holding GEHC

Investment Research & Advisory Group's GEHC Position: Q2 2026 in Review

Investment Research & Advisory Group sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 110 shares — an estimated $8.19K sold.

Investment Research & Advisory Group first reported a position in GEHC in Q1 2023 and held it in 10 quarters. The position peaked at $379K in Q2 2023. 435 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Investment Research & Advisory Group reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Investment Research & Advisory Group sold 110 GE HealthCare shares in Q2 2026, an estimated $8.19K.
  • Investment Research & Advisory Group first reported a position in GE HealthCare in Q1 2023 and held it in 10 quarters.
  • Investment Research & Advisory Group's GE HealthCare position peaked at $379K in Q2 2023.
  • 435 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.